Serina Therapeutics, Inc.
corporate_fare Company Profile
Serina Therapeutics, Inc. (NYSE:SER) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 1 item for SER at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 8/10. Recent SEC coverage for SER spans 10-Q.
Recent high-impact activity:
- Serina Q3 10-Q: $19.4M Cash, Yet Going-Concern Doubt Persists
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 46,787 shares in SER as of the October 30, 2026 settlement, a 6.7% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 48.5% of SER volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.